Professor Shankar Balasubramanian knighted
Congratulations to Professor Shankar Balasubramanian who has been named a Knight Bachelor for services to science and medicine.
He co-invented next generation sequencing which has provided one of the most transformative changes in biology and medicine for several decades, and has led to the $1000 dollar human genome. He has also made important contributions to four-stranded DNA, known as G-quadruplexes, and their role in cancer. Professor Balasubramanian is Herchel Smith Professor of Medicinal Chemistry in the Department of Chemistry the University of Cambridge, Senior Group Leader at the Cancer Research UK Cambridge Institute and Fellow of Trinity College.
It is a great honour for me and a wonderful acknowledgement of the research that I have carried out in Cambridge with my co-workers and collaborators over the past two decades. I was particularly pleased to see recognition of our basic science and its impact on medicine, as I am jointly appointed between the Departments of Chemistry and Medicine.
– Professor Sir Shankar Balasubramanian, Cancer Research UK Cambridge Institute
Related News
See all news-
1M to advance AI powered personalised ovarian cancer care
19th February 2026
Researchers from our Brenton Group are part of an international team awarded the Global Ovarian Cancer Research Consortium’s inaugural AI Accelerator Grant.
Find out more -
Professor Sir Steve Jackson elected as a fellow of the American Association for Cancer Research
16th February 2026
Senior Group Leader Sir Steve Jackson has been elected as a Fellow of the American Association for Cancer Research Academy in the Class of 2026.
Find out more -
New immune pathway offers treatment hope for childhood brain tumours
3rd February 2026
A newly discovered immune pathway could lead to gentler treatments for multiple childhood brain cancers, according to new research from our Gilbertson Group published today in Nature Genetics.
Find out more